Despite trading near its 52-week high, British oil major BP is navigating significant pressure from two distinct fronts. While a...

The initial phase of drilling at the Corvo Uranium Project in Saskatchewan’s Athabasca Basin is now underway, spearheaded by Aventis...

In a market where dividend-focused exchange-traded funds often quietly accumulate significant technology holdings, one European ETF stands apart by design....

The biopharmaceutical company aTyr Pharma is entering a pivotal period for its lead therapeutic candidate, efzofitimod. Two major clinical and...

As spring approaches, Axsome Therapeutics finds itself at a critical juncture. The biopharmaceutical firm is strengthening its commercial footing with...

Uranium Energy Corp. presented its second-quarter fiscal 2026 results on March 10, revealing a mixed financial picture. The company benefits...

In a strategic move to bolster its core pharmaceutical business, Novartis has received expanded U.S. regulatory approval for its immunology...

Newmont Corporation is signaling to its investors that 2026 will be a year marked by volatility. The world's leading gold...

The Nemetschek Group has announced a proposal to its shareholders for a substantial increase in its annual dividend. The software...

The world's largest chemical company is advancing its historic corporate overhaul at a faster pace than initially projected. While a...